Evidence map›Paper›PMID 38690470›Full record

ReviewCureus2024

Multifaceted Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on ST-Elevation Myocardial Infarction (STEMI): A Literature Review of Incidence, Treatment Modalities, and Outcomes.

Hoi K Choi, Madhurima Maity, Mohammed Qureshi, Ali Haider, Sagar Kapadia, Sofia Fuerte, Simon Antony, Waleed Razzaq, Anum Akbar

Open access · diamondAbstract readReview
In one paragraph

Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 5 countries.

Hoi K ChoiInternal Medicine, University of Michigan, Ann Arbor, USA.
Madhurima MaityInternal Medicine, Sir H. N. Reliance Foundation Hospital and Research Centre, Mumbai, IND.
Mohammed QureshiInternal Medicine, American University of the Caribbean School of Medicine, Cupecoy, SXM.
Ali HaiderMedicine, Quetta Institute of Medical Sciences, Quetta, PAK.
Sagar KapadiaEmergency Medicine, Jio World Centre, Mumbai, IND.
Sofia FuerteInternal Medicine, Instituto Tecnológico y de Estudios Superiores de Monterrey, Monterrey, MEX.
Simon AntonyInternal Medicine, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.
Waleed RazzaqInternal Medicine, Services Hospital, Lahore, PAK.
Anum AkbarPediatrics, University of Nebraska Medical Center, Omaha, USA.
World Health Organization - Pakistan · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The global repercussions of coronavirus disease 2019 (COVID-19) include substantial worldwide mortality and have brought to light existing gaps in healthcare systems. Particularly, diseases requiring time-sensitive treatment, such as ST-elevation myocardial infarction (STEMI), have faced significant challenges due to the impact and revelations of the COVID-19 pandemic on healthcare infrastructure. This review addresses the impact of the pandemic on STEMI, exploring incidence, treatment modalities, and clinical outcomes. Through a critical examination of existing literature, the intricate relationship between the pandemic and cardiovascular health, specifically STEMI, is elucidated. The COVID-19 pandemic has had a significant impact on the management of STEMI, with changes in hospitalization rates, treatment strategies, and the presentation of the disease posing significant challenges. The contradictory results of COVID-19 and post-vaccine myocardial infarction, as well as gender differences in reported cases, highlight the need for further research to clarify these relationships.

Indexed as

acute coronary syndromecovid-19covid-19 vaccinationmyocardial infarctionst-elevation myocardial infarction (stemi)

Identifiers

PMID38690470
PMCPMC11059148
OpenAlexW4395066358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.